SCM
RYTM icon

Sterling Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Sterling Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5K Sell
194
-149
-43% -$13.5K ﹤0.01% 1852
2026
Q1 		$29.8K Sell
343
-1
-0.3% -$97 ﹤0.01% 1841
2025
Q4 		$36.8K Buy
344
+217
+171% +$23K ﹤0.01% 1923
2025
Q3 		$12.8K Sell
127
-5
-4% -$464 ﹤0.01% 2358
2025
Q2 		$8.34K Buy
132
+74
+128% +$4.53K ﹤0.01% 2242
2025
Q1 		$3.07K Buy
58
+2
+4% +$111 ﹤0.01% 2398
2024
Q4 		$3.13K Hold
56
– – ﹤0.01% 2635
2024
Q3 		$2.93K Buy
+56
New +$2.68K ﹤0.01% 2008

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sterling Capital Management's RYTM Position: Q2 2026 in Review

Sterling Capital Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 43% in Q2 2026, selling an estimated $13.5K and leaving 194 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

Sterling Capital Management first reported a position in RYTM in Q3 2024 and has held it in 8 quarters since. The position peaked at $36.8K in Q4 2025. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Sterling Capital Management held 194 shares of Rhythm Pharmaceuticals worth $21.5K as of Q2 2026.
  • Sterling Capital Management sold 149 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $13.5K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1852 holding.
  • Sterling Capital Management first reported a position in Rhythm Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Rhythm Pharmaceuticals position peaked at $36.8K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.